Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00230204
Status:
UNKNOWN
Last Update Posted:
2006-02-16
First Post:
2005-09-29
Brief Title:
Infections and Autoimmunity Autobodies Screening in Multiple Sclerosis
Sponsor:
Sheba Medical Center
Organization:
Sheba Medical Center
Study Overview
Official Title:
Antibodies Screening in Multiple Sclerosis as a Part of an International Survey in Autoimmune Diseases
Status:
UNKNOWN
Status Verified Date:
2006-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this investigation is to assess the prevalence of infectious disease seropositivity toxoplasmosis rubella cytomegalovirus CMV herpes simplex virus type 1 HSV-1 and herpes simplex virus type 2 HSV-2 syphilis Epstein-Barr virus and H pylori in a group of patients presenting with specific autoimmune diseases rheumatoid arthritis RA undifferentiated connective tissue disorder UCTD Sjogren antiphospholipid syndrome - APS vasculitides systemic lupus erythematosus SLE polymyositis Hashimoto multiple sclerosis primary biliary cirrhosis PBC etc using the BioPlex 2200 and complementary EIA kits as compared to matched controls by age sex and ethnicity
Detailed Description:
The purpose of this investigation is to assess the prevalence of infectious disease seropositivity toxoplasmosis rubella cytomegalovirus CMV herpes simplex virus type 1 HSV-1 and herpes simplex virus type 2 HSV-2 syphilis Epstein-Barr virus and H pylori in a group of patients presenting with specific autoimmune diseases RA UCTD Sjogren antiphospholipid syndrome - APS vasculitides SLE polymyositis Hashimoto multiple sclerosis PBC etc using the BioPlex 2200 and complementary EIA kits as compared to matched controls by age sex and ethnicity
We will assess in our Center 100 patients with multiple sclerosis for the antibody profile of different infectious agents Comparative assessments will be performed with normal matched subjects
We will assess in our Center 100 patients with multiple sclerosis for the antibody profile of different infectious agents Comparative assessments will be performed with normal matched subjects
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None